Saturday 10 October 2026
Export all AZN data to Excel Powerpack
AstraZeneca PLC
AZN Healthcare Drug Manufacturers General
AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.41%, EPS grew 1.90%, free cash flow fell 107.5% and total debt fell 5.50%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five; insiders bought in the last twelve months.
159.20
0.42
+0.26%
Follow AZN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
27.86 | 28.74 | 35.44 | 64.79 | 388.33 | 40.64 | 94.08 | 44.68 | 29.73 | 19.94 |
Piotroski F-Score |
9 | 6 | 7 | 7 | 5 | 7 | 6 | 4 | 3 | 6 |
P/S ratio |
9.70 | 7.51 | 4.63 | 4.84 | 4.42 | 4.93 | 5.32 | 4.36 | 3.99 | 3.05 |
Altman Z-Score |
6.26 | 4.71 | 2.70 | 2.65 | 1.95 | 2.29 | 2.23 | 1.90 | 1.80 | 1.68 |
Altman Z″-Score (non-manufacturers) |
1.80 | 1.30 | 0.90 | 0.65 | 0.97 | 1.03 | 0.52 | 0.92 | 0.85 | 1.12 |
P/FCF ratio |
64.63 | 54.50 | 30.32 | 26.95 | 37.86 | 40.36 | 49.48 | 26.76 | 26.22 | 20.99 |
Beneish M-Score |
(2.51) | (2.59) | (2.58) | (2.75) | (2.20) | (2.40) | (2.59) | (2.54) | (2.48) | (2.74) |
P/Operating CF |
243.37 | 139.74 | 89.04 | 89.51 | 116.50 | 72.96 | 94.35 | 43.27 | 89.85 | 35.77 |
Dividend Safety Score |
54 | — | — | — | — | — | — | — | — | — |
P/B ratio |
11.70 | 9.94 | 5.41 | 5.79 | 4.20 | 8.39 | 8.89 | 6.85 | 5.38 | 4.21 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
10.08 | 7.94 | 5.09 | 5.33 | 5.04 | 5.36 | 5.78 | 4.95 | 4.58 | 3.52 |
EV/EBITDA |
30.39 | 25.72 | 17.18 | 25.60 | 24.85 | 17.17 | 21.09 | 15.32 | 15.31 | 11.16 |
EV/Operating CF |
40.61 | 36.20 | 22.55 | 24.11 | 31.61 | 29.74 | 47.50 | 41.79 | 28.73 | 19.54 |
EV/FCF |
67.12 | 57.61 | 33.38 | 29.68 | 43.21 | 43.92 | 53.79 | 30.42 | 30.09 | 24.25 |
Quick Ratio |
0.72 | 0.74 | 0.64 | 0.67 | 0.74 | 0.76 | 0.68 | 0.72 | 0.62 | 0.72 |
Current Ratio |
0.94 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | 0.86 | 0.96 | 0.80 | 0.87 |
Net Debt/EBITDA |
1.13 | 1.39 | 1.58 | 2.36 | 3.07 | 1.39 | 1.69 | 1.85 | 1.97 | 1.50 |
Debt/Assets |
24.39% | 27.72% | 27.19% | 29.31% | 28.28% | 29.52% | 28.60% | 31.51% | 28.11% | 26.88% |
Debt/Equity |
0.57 | 0.71 | 0.70 | 0.76 | 0.76 | 1.26 | 1.20 | 1.36 | 1.07 | 1.01 |
Asset Turnover |
0.54 | 0.53 | 0.46 | 0.44 | 0.43 | 0.42 | 0.40 | 0.36 | 0.36 | 0.38 |
Operating CF/Net income |
1.43 | 1.69 | 1.74 | 2.98 | 53.24 | 1.50 | 2.22 | 1.21 | 1.19 | 1.18 |
Capex/Depreciation |
(1.00) | (0.66) | (0.62) | (0.34) | (0.24) | (0.49) | (0.09) | 0.26 | (0.05) | (0.34) |
Interest Coverage |
8.11 | 5.74 | 5.04 | 2.79 | 0.81 | 3.95 | 2.04 | 2.39 | 2.44 | 3.54 |
| 22.83% | 17.58% | 15.63% | 8.61% | 0.41% | 21.14% | 9.32% | 14.05% | 18.02% | 19.89% | |
| 9.38% | 6.86% | 6.03% | 3.26% | 0.13% | 4.99% | 2.19% | 3.48% | 4.77% | 5.71% | |
ROIC |
12.15% | 9.77% | 8.45% | 3.99% | 1.05% | 11.86% | 7.06% | 7.78% | 7.69% | 11.12% |
Return on Tangible Assets |
92.38% | 85.66% | 152.15% | 68.40% | 0.87% | 42.68% | 26.00% | 32.07% | 68.48% | 72.08% |
Average Days of Receivables |
101.50 | 100.11 | 107.98 | 92.60 | 100.54 | 101.28 | 90.50 | 95.52 | 89.90 | 79.33 |
Research and Development Expense of Revenue |
24.23% | 25.12% | 23.87% | 22.01% | 26.02% | 22.51% | 24.85% | 26.85% | 25.63% | 25.61% |
Selling, General and Administrative Expense of Revenue |
34.92% | 37.97% | 43.12% | 42.74% | 41.91% | 43.93% | 49.30% | 46.91% | 46.93% | 42.34% |
Intangible Assets out of Total Assets |
0.52 | 0.56 | 0.57 | 0.61 | 0.59 | 0.49 | 0.53 | 0.56 | 0.60 | 0.63 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.06) | (0.09) | (0.17) | (0.17) | (0.24) | (0.24) | (0.24) | (0.32) | (0.37) | (0.46) |
Graham Number |
48.31 | 36.78 | 46.86 | 33.95 | 13.68 | 25.69 | 16.36 | 20.59 | 26.53 | 28.71 |
Earnings Yield |
3.59% | 3.48% | 2.82% | 1.54% | 0.26% | 2.46% | 1.06% | 2.24% | 3.36% | 5.02% |
Free Cash Flow Yield |
1.55% | 1.83% | 3.30% | 3.71% | 2.64% | 2.48% | 2.02% | 3.74% | 3.81% | 4.76% |
Revenue per Share |
18.95 | 17.44 | 29.57 | 28.65 | 26.39 | 20.29 | 18.74 | 17.43 | 17.74 | 18.18 |
Operating CF per Share |
4.70 | 3.83 | 6.68 | 6.34 | 4.21 | 3.66 | 2.28 | 2.07 | 2.83 | 3.28 |
Capex per Share |
(1.86) | (1.42) | (2.17) | (1.19) | (1.13) | (1.18) | (0.27) | 0.77 | (0.13) | (0.64) |
Free Cash Flow per Share |
2.84 | 2.40 | 4.51 | 5.15 | 3.08 | 2.48 | 2.02 | 2.84 | 2.70 | 2.64 |
Cash per Share |
1.88 | 1.84 | 3.92 | 4.19 | 4.57 | 6.20 | 4.81 | 4.69 | 3.62 | 4.69 |
Shareholders Equity per Share |
15.72 | 13.18 | 25.28 | 23.94 | 27.71 | 11.92 | 11.22 | 11.08 | 13.15 | 13.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.72 | 13.18 | 25.28 | 23.94 | 27.71 | 11.92 | 11.22 | 11.08 | 13.15 | 13.18 |
Free Cash Flow |
8,819.00 | 7,453.00 | 6,990.00 | 7,966.00 | 4,363.00 | 3,250.00 | 2,622.00 | 3,597.00 | 3,417.00 | 3,340.00 |
Working Capital |
(1,894.00) | (2,039.00) | (5,488.00) | (3,700.00) | 3,650.00 | (763.00) | (2,554.00) | (701.00) | (3,233.00) | (1,994.00) |
Capital Expenditures |
(5,756.00) | (4,408.00) | (3,355.00) | (1,842.00) | (1,600.00) | (1,549.00) | (347.00) | 979.00 | (161.00) | (805.00) |
Net Current Asset Value |
(36,632.00) | (37,337.00) | (36,899.00) | (36,832.00) | (39,832.00) | (31,547.00) | (31,218.00) | (31,016.00) | (33,562.00) | (32,595.00) |
EV/EBIT |
43.07 | 42.92 | 28.48 | 62.93 | 178.51 | 27.65 | 48.23 | 32.30 | 27.96 | 16.52 |
Capex to Sales |
0.10 | 0.08 | 0.07 | 0.04 | 0.04 | 0.06 | 0.01 | (0.04) | 0.01 | 0.04 |
Price to Operating Income |
41.47 | 40.61 | 25.86 | 57.13 | 156.44 | 25.41 | 44.37 | 28.41 | 24.36 | 14.30 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.44 | 0.65 | 0.57 | 0.64 | 0.71 | 0.38 | 0.49 | 0.51 | 0.40 | 0.34 |
Cash ROIC |
10.71% | 9.88% | 9.61% | 11.09% | 5.77% | 7.48% | 6.83% | 9.20% | 8.75% | 8.48% |
Accounts Receivable Turnover |
3.77 | 3.81 | 3.69 | 4.11 | 4.23 | 3.96 | 4.12 | 3.90 | 4.27 | 3.83 |
Accounts Payable Turnover |
0.45 | 0.46 | 0.40 | 0.65 | 0.72 | 0.36 | 0.37 | 0.40 | 0.39 | 0.37 |
Inventory Turnover |
1.80 | 1.91 | 1.63 | 1.81 | 1.91 | 1.47 | 1.62 | 1.67 | 1.61 | 1.84 |
Average Days of Payables |
867.79 | 803.34 | 987.73 | 560.86 | 555.79 | 1,087.29 | 1,037.44 | 949.55 | 984.01 | 927.63 |
Days of Inventory on Hand |
225.08 | 189.10 | 239.45 | 138.42 | 263.63 | 277.18 | 236.83 | 213.71 | 256.55 | 206.47 |
Average Receivables |
15,583.00 | 14,191.50 | 12,402.00 | 10,779.50 | 8,846.50 | 6,716.00 | 5,913.50 | 5,657.00 | 5,266.00 | 6,004.00 |
Average Payables |
23,872.50 | 22,419.50 | 20,707.00 | 18,989.00 | 17,361.50 | 14,886.00 | 13,414.00 | 12,241.00 | 11,063.50 | 11,074.50 |
Average Inventory |
5,922.50 | 5,356.00 | 5,061.50 | 6,841.00 | 6,503.50 | 3,608.50 | 3,041.50 | 2,962.50 | 2,684.50 | 2,238.50 |
Average Assets |
109,054.50 | 102,577.00 | 98,801.00 | 100,923.00 | 86,046.00 | 64,053.00 | 61,014.00 | 62,002.50 | 62,940.00 | 61,291.00 |
Average Common Equity |
44,795.00 | 40,018.50 | 38,112.00 | 38,172.50 | 27,462.50 | 15,117.00 | 14,320.00 | 15,343.00 | 16,655.50 | 17,589.00 |
Columns are period end dates